Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 12/20 | 0.43 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.39 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA4 | P22748 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | GHSR | Q92847 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6440943 | 0.97 | PTGS2 (0.44) | PTGS2ESR2PTGS1GHSR | |
| SCHEMBL6438018 | 0.93 | PTGS2 (0.43) | PTGS2ESR2PTGS1GHSR | |
| SCHEMBL6527042 | 0.90 | PTGS2 (0.45) | PTGS2ESR2PTGS1CA12CA1 | |
| SCHEMBL6439880 | 0.87 | PTGS2 (0.49) | PTGS2PTGS1GHSR | |
| SCHEMBL6438496 | 0.86 | PTGS2 (0.43) | PTGS2ESR2PTGS1GHSR | |
| SCHEMBL6439645 | 0.84 | PTGS2 (0.42) | PTGS2ESR2PTGS1GHSR | |
| SCHEMBL6439748 | 0.84 | PTGS2 (0.44) | PTGS2PTGS1GHSR | |
| SCHEMBL4957399 | 0.82 | PTGS2 (0.43) | PTGS2ESR2PTGS1 | |
| SCHEMBL5150658 | 0.81 | ESR2 (0.41) | PTGS2ESR2PTGS1CA12CA1 | |
| SCHEMBL5148416 | 0.81 | ESR2 (0.41) | PTGS2ESR2PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1534683-A4 | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2005-08-24 | — | — | EP | disclosed |
| EP-1534683-A2 | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004002409-A2 | CYCLOOXYGENASE-2 SELECTIVE INHIBITORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2004-01-08 | — | — | WO | disclosed |